Dishman Pharma of India and Polpharma of Poland has signed a collaboration and joint API development agreement.
According to both the companies, this partnership will help mutually and pave the way for a stronger growth in coming years.
Polpharma is particularly a strong player in its home market and a leader in the Central and Eastern European markets and CIS countries with a turnover of US$400mn.
Polpharma is also a CEE leader in the API sales with almost 90% of which in regulated markets, including USA. The Dishman group, a dedicated CRM player has a turnover of US$200mn.
|
